IRIS
SARMATI, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 64.023
AS - Asia 10.539
EU - Europa 8.720
SA - Sud America 1.592
Continente sconosciuto - Info sul continente non disponibili 1.233
AF - Africa 218
OC - Oceania 105
Totale 86.430
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 63.440
SG - Singapore 4.485
IT - Italia 2.245
CN - Cina 1.831
BR - Brasile 1.271
RU - Federazione Russa 1.175
DE - Germania 1.076
HK - Hong Kong 974
VN - Vietnam 801
IE - Irlanda 716
UA - Ucraina 714
BD - Bangladesh 679
KR - Corea 673
SE - Svezia 522
GB - Regno Unito 509
FR - Francia 484
FI - Finlandia 395
CA - Canada 296
JP - Giappone 282
IN - India 232
PL - Polonia 213
NL - Olanda 163
ES - Italia 122
MX - Messico 105
AR - Argentina 98
AU - Australia 96
ID - Indonesia 91
AT - Austria 89
TR - Turchia 87
BE - Belgio 77
ZA - Sudafrica 72
IQ - Iraq 68
CO - Colombia 61
CZ - Repubblica Ceca 51
EC - Ecuador 47
PK - Pakistan 47
CR - Costa Rica 45
PH - Filippine 41
JM - Giamaica 37
CL - Cile 34
VE - Venezuela 30
LT - Lituania 26
SA - Arabia Saudita 26
CH - Svizzera 25
MA - Marocco 24
AE - Emirati Arabi Uniti 21
PY - Paraguay 21
KG - Kirghizistan 20
TN - Tunisia 20
HN - Honduras 19
IL - Israele 19
JO - Giordania 18
KE - Kenya 18
RO - Romania 18
UZ - Uzbekistan 18
EG - Egitto 16
TW - Taiwan 16
EU - Europa 14
MY - Malesia 14
TT - Trinidad e Tobago 14
IR - Iran 13
KZ - Kazakistan 13
NI - Nicaragua 13
DZ - Algeria 12
GR - Grecia 12
PE - Perù 12
UY - Uruguay 11
BH - Bahrain 10
CM - Camerun 10
NP - Nepal 10
PT - Portogallo 10
DO - Repubblica Dominicana 9
GT - Guatemala 9
NG - Nigeria 9
NZ - Nuova Zelanda 9
TH - Thailandia 9
AL - Albania 8
AZ - Azerbaigian 7
BB - Barbados 7
BG - Bulgaria 7
ET - Etiopia 7
LB - Libano 7
PR - Porto Rico 7
SI - Slovenia 7
SV - El Salvador 7
DK - Danimarca 6
LV - Lettonia 6
NO - Norvegia 6
PA - Panama 6
SC - Seychelles 6
XK - ???statistics.table.value.countryCode.XK??? 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BA - Bosnia-Erzegovina 5
HR - Croazia 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
EE - Estonia 4
MD - Moldavia 4
Totale 85.155
Salva come PNG Salva come JPEG
Città #
Woodbridge 14.891
Wilmington 14.693
Houston 11.315
Singapore 2.504
Ashburn 2.136
Fairfield 1.826
San Jose 1.703
Ann Arbor 1.390
Chandler 1.361
Hong Kong 951
Seattle 784
Beijing 718
Rome 709
Council Bluffs 678
Cambridge 630
Dublin 625
New York 605
Jacksonville 597
Los Angeles 556
Medford 450
The Dalles 411
Santa Clara 405
Dearborn 396
Tokyo 259
Ho Chi Minh City 258
Lawrence 214
Buffalo 212
Dallas 207
Helsinki 206
Hanoi 200
Milan 188
Moscow 166
Denver 153
São Paulo 152
Orem 149
Munich 148
San Diego 142
Lauterbourg 140
Kraków 121
Chicago 115
Boardman 107
Atlanta 104
London 104
Nuremberg 101
Menlo Park 96
Phoenix 96
North Bergen 92
Zhengzhou 85
Montreal 84
Brussels 76
Chennai 74
Mülheim 72
Brooklyn 70
Redondo Beach 70
Toronto 68
Frankfurt am Main 67
Warsaw 63
Naples 59
Stockholm 54
Jakarta 52
Amsterdam 48
Johannesburg 48
Manchester 48
Rio de Janeiro 45
Palo Alto 44
Guangzhou 43
Shanghai 42
Washington 42
San Francisco 41
Sydney 41
San Mateo 40
Lappeenranta 38
Hangzhou 37
Mexico City 37
Falls Church 36
Norwalk 34
Salt Lake City 34
Redwood City 33
Melbourne 32
Brno 31
Da Nang 31
Engelhard 31
Hefei 31
Verona 31
Boston 30
Colorado Springs 30
Columbus 30
San José 30
Florence 29
Mumbai 29
Vienna 29
Belo Horizonte 28
Haiphong 28
Ankara 27
Nanjing 27
Paris 27
Philadelphia 27
Poplar 27
Baghdad 26
Bologna 26
Totale 66.326
Salva come PNG Salva come JPEG
Nome #
Persistent risk of HBV reactivation despite extensive lamivudine prophylaxis in haematopoietic stem cell transplant recipients who are anti-HBc-positive or HBV-negative recipients with an anti-HBc-positive donor 593
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 593
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 569
Microbiologic characteristics and predictors of mortality in bloodstream infections in intensive care unit patients: A 1-year, large, prospective surveillance study in 5 Italian hospitals 556
Emergence of KPC-producing Klebsiella pneumoniae in Italy 553
18-Fluoro-2-deoxyglucose positron emission tomography-computed tomography: an additional tool in the diagnosis of prosthetic valve endocarditis. 543
Leflunomide-induced DRESS syndrome 542
Clinical predictors and microbiology of ventilator-associated pneumonia in the intensive care unit: a retrospective analysis in six Italian hospitals 538
Human herpesvirus-8 infection in pregnancy and labor: Lack of evidence of vertical transmission 518
Italian consensus Guidelines for the management of hepatitis B virus infections in patients with rheumatoid arthritis 507
Prognostic factors of long-term CD4+ count-guided interruption of antiretroviral treatment 498
Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression 498
Infection with human herpesvirus type 8 and Kaposi's sarcoma in a central Italian area formerly endemic for malaria 497
Replication capacity, biological phenotype, and drug resistance of HIV strains isolated from patients failing antiretroviral therapy 495
A stable CC-chemokine receptor (CCR)-5 tropic virus is correlated with the persistence of HIV RNA at less than 2.5 copies in successfully treated naïve subjects. 494
A relapsing inflammatory syndrome and active human herpesvirus 8 infection 491
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 490
Cellular HIV-1 DNA quantitation in patients during simplification therapy with protease inhibitor-sparing regimens 489
Novelties in evaluation and monitoring of human immunodeficiency virus-1 infection: Is standard virological suppression enough for measuring antiretroviral treatment success? 488
Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naive to the antiretroviral drugs 481
HIV-1 residual viremia and proviral DNA in patients with suppressed plasma viral load (< 400 HIV-RNA cp/ml) during different antiretroviral regimens 478
A fatal case of invasive fungal sinusitis by Scopulariopsis acremonium in a bone marrow transplant recipient 476
Efficient and reproducible new semimicromethod for the detection and titration of HIV in human plasma 473
Drug-associated resistance mutations in plasma and peripheral blood mononuclear cells of human immunodeficiency virus type 1-infected patients for whom highly active antiretroviral therapy is failing 471
HIV plasma viremia in 22 seropositive subjects [VALUTAZIONE DELLA VIREMIA PLASMATICA DA HIV IN 22 SOGGETTI SIERO-POSITIVI] 471
Candida Albicans Peritoneal Infection in a patient with slerosing Encapsulating Peritonitis under continous peritoneal dialysis. Efficacy of intra-abdominal Amphotericin B and negative pressure after failure of a systemic therapy 468
Advances in herpesvirus diagnosis 467
Hepatitis B reactivation characterized by HBsAg negativity and anti-HbsAg antibodies persistence in haematopoietic stem cell transplanted patient after lamivudine withdrawal 467
Decrease of replicative capacity of HIV isolates after genotypic guided change of therapy 463
HIV-1 dual/mixed tropic isolates show different genetic and phenotypic characteristics and response to maraviroc in vitro 463
Correlation between changes in plasma HIV RNA levels and in plasma infectivity in response to antiretroviral therapy. 462
High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. 462
Clinical outcome after 4 years follow-up of HIV-seropositive subjects with incomplete virologic or immunologic response to HAART 460
Human herpesvirus 8 and human herpesvirus 2 infections in prison population 459
Association between cellular human immunodeficiency virus DNA level and immunological parameters in patients with undetectable plasma viremia level during highly active antiretroviral therapy 459
Neutralizing antibodies against autologous human immunodeficiency virus type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment 457
High prevalence of M184 mutation among patients with viroimmunologic discordant responses to highly active antiretroviral therapy and outcomes after change of therapy guided by genotypic analysis 455
Reduction of IFN-gamma and IL-2 production by peripheral lymphocytes of HIV-exposed seronegative subjects 454
HIV phenotype switching during antiretroviral therapy: emergence of saquinavir-resistant strains with less cytopathogenicity 454
Failure of stavudine-lamivudine combination therapy in antiretroviral-naive patients with AZT-like HIV-1 resistance mutations 453
Cortical sources of resting state electroencephalographic rhythms probe brain function in naïve HIV individuals 452
A case of rhabdomiolysis associated with raltegravir use 451
A very low geno2pheno false positive rate is associated with poor viro-immunological response in drug-naïve patients starting a first-line HAART. 449
Viral growth assay to evaluate the replicative capacity of HIV-1 isolates 448
Five human immunodeficiency virus type 1 phenotypic variants with different MT-2 cell tropisms correlate with prognostic markers of disease 447
ellular proviral HIV-DNA decline and viral isolation in naïve subjects with <5000 copies/ml of HIV-RNA and >500 x 10(6)/l CD4 cells treated with highly active antiretroviral therapy. 446
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration 445
Drug resistance in B and non-B subtypes amongst subjects recently diagnosed as primary/recent or chronic HIV-infected over the period 2013-2016: impact on susceptibility to first-line strategies including Integrase strand-transfer inhibitors 445
Dapsone hypersensitivity syndrome complicated by Scedosporium apiospermum pneumonia in an immunocompetent patient. 444
Correlates of HIV, HBV, and HCV infections in a prison inmate population: Results from a multicentre study in Italy 443
Increase in neutralizing antibody titer against sequential autologous HIV-1 isolates after 16 weeks saquinavir (invirase) treatment 442
Late hepatitis B virus reactivation after lamivudine prophylaxis interruption in an anti-HBs-positive and anti-HBc-negative patient treated with rituximab-containing therapy 442
Infection with human herpesvirus-8 and its correlation with hepatitis B virus and hepatitis C virus markers among rural populations in Cambodia 441
Characterization of drug resistance mutations in naive and ART-treated patients infected with HIV-1 in Yaounde, Cameroon 440
Interleukin-15 production by monocyte-derived dendritic cells and T cell proliferation in HIV-infected patients with discordant response to highly active antiretroviral therapy 439
Management of carbapenem resistant Klebsiella pneumoniae infections in stem cell transplant recipients: An italian multidisciplinary consensus statement 438
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation 437
Complication of nasal piercing by Staphylococcus aureus endocarditis: a case report and a review of literature. 437
Adherence and genotypic drug resistance mutations in HIV-1-infected patients failing current antiretroviral therapy 437
HIV neutralizing antibody titer during structured treatment interruption of highly active antiretroviral therapy 436
Prevalence of HHV-8 infection in Albanian adults and association with HBV and HCV 434
Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study 434
Plasma Viremia Titration and RNA Quantitation in ICD-p24 Negative HIV Type-1-Infected Patients 433
KSHV DNA viremia correlates with low CD4+ cell count in Italian males at the time of diagnosis of HIV infection 431
Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon 431
Human herpesvirus 8 cytoviraemia rebound in a patient with Kaposi's sarcoma after a short interruption of efficient antiretroviral therapy. 431
Secondary integrase resistance mutations found in HIV-1 minority quasispecies in integrase therapy-naive patients have little or no effect on susceptibility to integrase inhibitors 428
Usefulness of QuantiFERON®-TB Gold test in psoriatic patients under treatment with tumour necrosis factor blockers 428
Saquinavir/zidovudine combination in patients with advanced HIV infection and no prior antiretroviral therapy: CD4+ lymphocyte/plasma RNA changes, and emergence of HIV strains with reduced phenotypic sensitivity. 428
Improvement of ALT decay kinetics by all-oral HCV treatment: Role of NS5A inhibitors and differences with IFN-based regimens 428
Infection with human herpesvirus type 8 and human T-cell leukaemia virus type 1 among individuals participating in a case-control study in Havana City, Cuba 427
Inhibition of dual/mixed tropic HIV-1 isolates by CCR5-inhibitors in primary lymphocytes and macrophages 427
Prevalence trend and correlates of HHV-8 infection in HIV-infected patients 426
HBV, HCV, HDV AND HEV COINFECTIONS IN A COHORT OF HIV POSITIVE PATIENTS IN CAMEROON 426
Primary human herpesvirus 8 infection in immunocompetent children. 426
High Burden of HBV-Infection and Atypical HBV Strains among HIV-infected Cameroonians 421
Estimating minimum adult HIV prevalence: A cross-sectional study to assess the characteristics of people living with HIV in Italy 421
High rate of HIV isolation from plasma of asymptomatic patients through polyethylene glycol (PEG) treatment 420
Efficacy of cidofovir on human herpesvirus 8 viraemia and Kaposi's sarcoma progression in two patients with AIDS [1] 418
Erysipeloid cutaneous metastasis from bladder carcinoma 416
Nevirapine use, prolonged antiretroviral therapy and high CD4 nadir values are strongly correlated with undetectable HIV-DNA and -RNA levels and CD4 cell gain. 415
Non-B HIV type 1 subtypes: Replicative capacity and response to antiretroviral therapy 414
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literature 414
Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy 412
Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review 412
ISS-NIA Study Group. Response to raltegravir-based salvage therapy in HIV-infected patients with hepatitis C virus or hepatitis B virus coinfection. 411
HHV-8 infection in African children 410
Serological testing for human herpesvirus 8 410
Saquinavir delays the emergence of zidovudine resistance in HIV-1 seropositive patients treated with combination therapy. 410
Development of cellulitis caused by Aeromonas hydrophila in allogeneic hematopoietic transplantation: a case report. 408
Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: a cross-sectional evaluation 407
HIV-1 integrase genotyping is reliable and reproducible for routine clinical detection of integrase resistance mutations even in patients with low-level viraemia 407
Structural equation modelling of viral tropism reveals its impact on achieving viral suppression within 6 months in treatment-naive HIV-1-infected patients after combination antiretroviral therapy 407
Infection with human immunodeficiency virus, herpes simplex virus type 2, and human herpes virus 8 in remote villages of southwestern Papua New Guinea 406
Reply to 'Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non-nucleosides', by Barreiro et al. [2] 405
Human herpesvirus 8 seropositivity and risk of Kaposi's sarcoma and other acquired immunodeficiency syndrome-related diseases. 404
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 404
Stavudine protective function and emergence of lamivudine resistance [4] (multiple letters) 404
Janus-faced liposomes enhance antimicrobial innate immune response in Mycobacterium tuberculosis infection 401
Human immunodeficiency virus polymorphisms and zidovudine resistance 399
Totale 45.258
Salva come PNG Salva come JPEG
Categoria #
all - tutte 240.491
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 240.491
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.400 0 0 0 170 124 396 205 145 302 233 172 653
2022/20233.599 324 298 224 517 297 756 271 242 341 31 191 107
2023/20241.713 213 44 167 102 163 343 81 124 39 122 44 271
2024/20257.789 286 1.344 731 642 272 544 767 464 771 762 620 586
2025/202614.018 1.148 595 1.334 1.215 1.217 591 1.826 1.585 1.755 1.214 834 704
2026/20275.542 1.043 766 2.474 1.259 0 0 0 0 0 0 0 0
Totale 86.430